These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16874533)

  • 1. [Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus].
    Ständer S; Reinhardt HW; Luger TA
    Hautarzt; 2006 Sep; 57(9):801-7. PubMed ID: 16874533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study.
    Szepietowski JC; Szepietowski T; Reich A
    Acta Dermatovenerol Croat; 2005; 13(2):97-103. PubMed ID: 16324422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia.
    Phan NQ; Siepmann D; Gralow I; Ständer S
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):88-91. PubMed ID: 19744255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids for the treatment of chronic pruritus: A review.
    Avila C; Massick S; Kaffenberger BH; Kwatra SG; Bechtel M
    J Am Acad Dermatol; 2020 May; 82(5):1205-1212. PubMed ID: 31987788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipruritic effects of pimecrolimus and tacrolimus].
    Ständer S; Luger TA
    Hautarzt; 2003 May; 54(5):413-7. PubMed ID: 12719860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment strategy and assessment questionnaire for external auditory canal pruritus: topical pimecrolimus therapy and Modified Itch Severity Scale.
    Acar B; Karabulut H; Sahin Y; Babademez MA; Karadag AS; Karasen RM
    J Laryngol Otol; 2010 Feb; 124(2):147-51. PubMed ID: 19922703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial.
    Castello M; Milani M
    G Ital Dermatol Venereol; 2011 Oct; 146(5):321-5. PubMed ID: 21956268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients.
    Yuan C; Wang XM; Guichard A; Tan YM; Qian CY; Yang LJ; Humbert P
    Clin Interv Aging; 2014; 9():1163-9. PubMed ID: 25071367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Body Lotion Containing N-palmitoylethanolamine in Subjects with Chronic Pruritus due to Dry Skin: A Dermatocosmetic Study.
    Visse K; Blome C; Phan NQ; Augustin M; Ständer S
    Acta Derm Venereol; 2017 May; 97(5):639-641. PubMed ID: 27983740
    [No Abstract]   [Full Text] [Related]  

  • 11. Itch Management: Topical Agents.
    Metz M; Staubach P
    Curr Probl Dermatol; 2016; 50():40-5. PubMed ID: 27578070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.
    Noli C; Della Valle MF; Miolo A; Medori C; Schievano C;
    Vet Dermatol; 2015 Dec; 26(6):432-40, e101. PubMed ID: 26283633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
    Drake LA; Millikan LE
    Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin and pregabalin for the treatment of chronic pruritus.
    Matsuda KM; Sharma D; Schonfeld AR; Kwatra SG
    J Am Acad Dermatol; 2016 Sep; 75(3):619-625.e6. PubMed ID: 27206757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rational symptomatic therapy for chronic pruritus].
    Ständer S
    Hautarzt; 2006 May; 57(5):403-10. PubMed ID: 16583225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch.
    Papoiu AD; Valdes-Rodriguez R; Nattkemper LA; Chan YH; Hahn GS; Yosipovitch G
    Acta Derm Venereol; 2013 Sep; 93(5):520-6. PubMed ID: 23474847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Nerve Fibre Activation in Patients with Generalized Chronic Pruritus: Hint for Central Sensitization?
    Pereira MP; Agelopoulos K; Köllner J; Neufang G; Schmelz M; Ständer S
    Acta Derm Venereol; 2019 Oct; 99(11):1009-1015. PubMed ID: 31289838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B; Eicke C; Reinhardt HW; Ring J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
    Brune A; Metze D; Luger TA; Ständer S
    Hautarzt; 2004 Dec; 55(12):1130-6. PubMed ID: 15517116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of prurigo nodularis with topical capsaicin.
    Ständer S; Luger T; Metze D
    J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.